Stocks

Stocks Market News

20 stories
globenewswire

Parsons Celebrates the Opening of the Gordie Howe International Bridge

Key Takeaways:CHANTILLY, Va., July 27, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation NYSE:PSN recognized today that Windsor-Detroit Bridge Authority opened the Gordie Howe International Bridge, which connects Detroit, Michigan and Windsor, Ontario, Canada. The bridge is a 2,800-foot-long cable-staye…

GlobeNewswire en_IN
EconomyStocksCAUS

BacTech Announces the Passing of Director Jay Richardson

(TheNewswire)Toronto, Ontario – July 27, 2026 – TheNewswire - BacTech Environmental Corporation (“BacTech” or the “Company”) CSE:BAC OTC:BCCEF announces with great sadness the passing of James A. “Jay” Richardson, a Director of the Company and Chair of its Audit Committee, on July 25, 2026, followi…

TheNewswire en_IN
StocksCA
globenewswire

Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund

July 27, 2026Q2 2026 Group performanceRoy Jakobs, CEO of Royal Philips:“We delivered another solid quarter with comparable sales growth of 4%, driven by all business segments, and strong disciplined execution within an uncertain macro environment. Customer demand for our innovations remains healthy…

GlobeNewswire en_IN
ETFsStocksNL

Pentixapharm Completes Capital Increase – New Shares Placed in Full

Pentixapharm Holding AG/ Key word(s): Capital IncreasePentixapharm Completes Capital Increase – New Shares Placed in Full27.07.2026 / 20:50 CET/CESTThe issuer is solely responsible for the content of this announcement.Pentixapharm completes capital increase and raises total gross proceeds of approx…

EQS en_IN
ETFsStocksDE

Pfizer and Eisai Commence Co-promotion of "NURTEC(R)" for the Acute Treatment and Prophylaxis (Preventive Treatment) of Migraine

TOKYO, July 27, 2026 - (JCN Newswire) - Pfizer Japan Inc. (Headquarters: Tokyo, President and Representative Director: Hiroo Igarashi, "Pfizer") and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the companies will commence the co-promotion of the oral calcito…

Japan Corporate News en_IN
StocksJP
tradingview

Nathan E. Tagg appointed to Independent Bank board and audit committee

Independent Bank appointed Nathan E. Tagg to its Board of Directors and Audit Committee, effective July 21, 2026, increasing the board size to 11 following the HCB Financial acquisition.Original SEC Filing: INDEPENDENT BANK CORP /MI/ [ IBCP ] - 8-K - Jul. 27, 2026This is an AI-powered summary. It m…

TradingView en_IN
StocksUS
NEWS cointelegraph

Securitize Capital becomes SEC-registered investment adviser

Securitize Capital, a subsidiary of tokenized asset platform Securitize, has registered with the US Securities and Exchange Commission (SEC) as an investment adviser, allowing the company to expand its regulated investment advisory business for institutional clients, Securitize said Monday.The regi…

Cointelegraph en_IN
ETFsStocksUS

Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today

Pentixapharm Holding AG / Key word(s): Capital measures / Capital increasePentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today27-Jul-2026 / 20:40 CET/CESTDisclosure of an inside…

EQS en_IN
ETFsStocksDE
zacks

Is VZ Stock a Buy After Verizon Raises Its 2026 Financial Outlook?

Verizon Communications VZ recently raised its 2026 financial outlook after reporting stronger profitability, improving subscriber trends and higher cash generation. The updated outlook reflects improving execution across its wireless and broadband businesses.Investors considering the stock can weig…

Zacks en_IN
StocksUS

LEGN Stock Plunges 15% After Sudden CEO Exit — But Analyst Reiterates Optimism In Company’s Under-Development Lymphoma Asset

Shares of Legend Biotech (LEGN) plunged about 15% on Monday after the cell therapy company announced a sudden CEO transition, and RBC Capital slashed its price target on the stock.Legend said on Monday that Ying Huang stepped down as chief executive officer and board member effective July 24.“Huang…

Stocktwits en_IN
StocksUS